- Home
- Publications
- Publication Search
- Publication Details
Title
Prognostic role of DOK family adapters in acute myeloid leukemia
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-23
DOI
10.1038/s41417-018-0052-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Methylation-associated DOK1 and DOK2 down-regulation: Potential biomarkers for predicting adverse prognosis in acute myeloid leukemia
- (2018) Pin-Fang He et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Acute myeloid leukemia induction with cladribine: Outcomes by age and leukemia risk
- (2018) Martin W. Schoen et al. LEUKEMIA RESEARCH
- Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
- (2017) S.K. Metzelder et al. EUROPEAN JOURNAL OF CANCER
- Genomics of Acute Myeloid Leukemia Diagnosis and Pathways
- (2017) Lars Bullinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Dok1 and Dok2 Proteins Regulate Cell Cycle in Hematopoietic Stem and Progenitor Cells
- (2016) Emilie Coppin et al. JOURNAL OF IMMUNOLOGY
- Acute Myeloid Leukemia
- (2015) Hartmut Döhner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dok1 and Dok2 proteins regulate natural killer cell development and function
- (2014) Javier Celis‐Gutierrez et al. EMBO JOURNAL
- Mutational analysis of the DOK2 haploinsufficient tumor suppressor gene in chronic myelomonocytic leukemia (CMML)
- (2014) E Coppin et al. LEUKEMIA
- Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- New insights into Dok-4 PTB domain structure and function
- (2012) Erika Hooker et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker
- (2012) H. Heyn et al. CARCINOGENESIS
- Age-Related Prognostic Impact of Different Types ofDNMT3AMutations in Adults With Primary Cytogenetically Normal Acute Myeloid Leukemia
- (2012) Guido Marcucci et al. JOURNAL OF CLINICAL ONCOLOGY
- RUNX1Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression Signatures
- (2012) Jason H. Mendler et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
- (2012) Jay P. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells
- (2011) U. Bacher et al. HAEMATOLOGICA
- Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD
- (2011) H. J. M. de Jonge et al. HAEMATOLOGICA
- RET in breast cancer: functional and therapeutic implications
- (2011) Andrea Morandi et al. TRENDS IN MOLECULAR MEDICINE
- Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis
- (2010) V. Gupta et al. BLOOD
- TrkC plays an essential role in breast tumor growth and metastasis
- (2010) Wook Jin et al. CARCINOGENESIS
- Mice lacking Dok-1, Dok-2 and Dok-3 succumb to aggressive histiocytic sarcoma
- (2010) Ryuichi Mashima et al. LABORATORY INVESTIGATION
- The roles of Dok family adapters in immunoreceptor signaling
- (2009) Ryuichi Mashima et al. IMMUNOLOGICAL REVIEWS
- Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome
- (2009) Elaine R. Mardis et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started